Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)

Summary

A randomized, controlled study of the safety and efficacy of Squalamine Lactate Eye Drops in combination with Ranibizumab intravitreal injections in patients with diabetic macular edema. The study duration is 52 weeks and patients will be randomized to one of four treatment arms.

Timeline

Start

2015-02

Primary completion

2015-09

Completion

2015-09

Outcome

Outcome not reported

Stopped (Enrollment): “Study cancelled as of 9/12/15. 0 subjects enrolled.”

Drugs

Indications